Source 1review2026MED
Toolkit/companion diagnostics for solid-tumor CAR-T therapy
companion diagnostics for solid-tumor CAR-T therapy
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Emerging targets such as B7-H3, Claudin 18.2, and MUC1, along with advancements in companion diagnostics, are reshaping the landscape of CAR-T therapy by enabling more precise patient selection and real-time therapeutic monitoring.
Usefulness & Problems
Why this is useful
Companion diagnostics are described as tools that support patient selection and real-time monitoring in CAR-T therapy for solid tumors.; patient selection; real-time therapeutic monitoring
Source:
Companion diagnostics are described as tools that support patient selection and real-time monitoring in CAR-T therapy for solid tumors.
Source:
patient selection
Source:
real-time therapeutic monitoring
Problem solved
The abstract explicitly links them to more precise patient selection and therapeutic monitoring.; imprecise patient selection; limited real-time monitoring of therapy
Source:
The abstract explicitly links them to more precise patient selection and therapeutic monitoring.
Source:
imprecise patient selection
Source:
limited real-time monitoring of therapy
Problem links
imprecise patient selection
LiteratureThe abstract explicitly links them to more precise patient selection and therapeutic monitoring.
Source:
The abstract explicitly links them to more precise patient selection and therapeutic monitoring.
limited real-time monitoring of therapy
LiteratureThe abstract explicitly links them to more precise patient selection and therapeutic monitoring.
Source:
The abstract explicitly links them to more precise patient selection and therapeutic monitoring.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Target processes
diagnosticselectionImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
They require diagnostic assays or monitoring workflows integrated with the therapeutic program.; requires diagnostic workflows linked to target expression or treatment monitoring
The abstract does not specify that diagnostics themselves overcome TME suppression, antigen escape, or infiltration barriers.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Advancements in companion diagnostics enable more precise patient selection and real-time therapeutic monitoring for CAR-T therapy in solid tumors.
Armored CAR-T cells are described as being equipped to counteract immunosuppressive signals in the tumor microenvironment.
Logic-gated CARs are described as enabling tumor-selective activation in solid-tumor CAR-T therapy.
Matrix-degrading enzymes and immune checkpoint inhibitors are discussed as means to overcome physical and immune-mediated resistance in solid tumors.
Approval Evidence
1 source1 linked approval claimfirst-pass slug companion-diagnostics-for-solid-tumor-car-t-therapy
Emerging targets such as B7-H3, Claudin 18.2, and MUC1, along with advancements in companion diagnostics, are reshaping the landscape of CAR-T therapy by enabling more precise patient selection and real-time therapeutic monitoring.
Source:
diagnostic rolesupports
Advancements in companion diagnostics enable more precise patient selection and real-time therapeutic monitoring for CAR-T therapy in solid tumors.
Source:
Comparisons
Source-stated alternatives
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Source:
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Source-backed strengths
enables more precise patient selection; enables real-time therapeutic monitoring
Source:
enables more precise patient selection
Source:
enables real-time therapeutic monitoring
Compared with CAR-T
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Shared frame: source-stated alternative in extracted literature
Strengths here: enables more precise patient selection; enables real-time therapeutic monitoring.
Source:
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Compared with CAR-T cells
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Shared frame: source-stated alternative in extracted literature
Strengths here: enables more precise patient selection; enables real-time therapeutic monitoring.
Source:
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Compared with CAR-T therapy
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Shared frame: source-stated alternative in extracted literature
Strengths here: enables more precise patient selection; enables real-time therapeutic monitoring.
Source:
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Compared with Chimeric Antigen Receptor (CAR) T-cell therapy
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Shared frame: source-stated alternative in extracted literature
Strengths here: enables more precise patient selection; enables real-time therapeutic monitoring.
Source:
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Compared with chimeric antigen receptor T cells
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Shared frame: source-stated alternative in extracted literature
Strengths here: enables more precise patient selection; enables real-time therapeutic monitoring.
Source:
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Compared with Chimeric antigen receptor T-cell therapy
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Shared frame: source-stated alternative in extracted literature
Strengths here: enables more precise patient selection; enables real-time therapeutic monitoring.
Source:
No direct diagnostic alternative is named in the abstract, but the review pairs diagnostics with engineering strategies such as logic-gated and armored CAR-T designs.
Ranked Citations
- 1.